Cargando…

Atrial Involvement in Cardiac Amyloidosis: Beyond Dilatation

[Figure: see text]

Detalles Bibliográficos
Autores principales:	Fontana, Marianna, Patel, Rishi K., Martinez-Naharro, Ana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352318/ https://www.ncbi.nlm.nih.gov/pubmed/34396287 http://dx.doi.org/10.1016/j.jaccao.2020.11.005

Ejemplares similares

Rare Forms of Cardiac Amyloidosis: Diagnostic Clues and Phenotype in Apo AI and AIV Amyloidosis
por: Ioannou, Adam, et al.
Publicado: (2023)

Clinical Importance of Left Atrial Infiltration in Cardiac Transthyretin Amyloidosis
por: Bandera, Francesco, et al.
Publicado: (2022)

Cardiac biomarkers are prognostic in systemic light chain amyloidosis with no cardiac involvement by standard criteria
por: Sharpley, Faye A., et al.
Publicado: (2020)

Imaging-Guided Treatment for Cardiac Amyloidosis
por: Ioannou, Adam, et al.
Publicado: (2022)

Disease progression in cardiac transthyretin amyloidosis is indicated by serial calculation of National Amyloidosis Centre transthyretin amyloidosis stage
por: Law, Steven, et al.
Publicado: (2020)

Cardiac Amyloidosis: A Review of Current Imaging Techniques
por: Razvi, Yousuf, et al.
Publicado: (2021)

Analysis of Cardiac Amyloidosis Progression Using Model-Based Markers
por: Li, Wenguang, et al.
Publicado: (2020)

Noninvasive Mapping of the Electrophysiological Substrate in Cardiac Amyloidosis and Its Relationship to Structural Abnormalities
por: Orini, Michele, et al.
Publicado: (2019)

Tracking Multiorgan Treatment Response in Systemic AL-Amyloidosis With Cardiac Magnetic Resonance Derived Extracellular Volume Mapping
por: Ioannou, Adam, et al.
Publicado: (2023)

Restricted left atrial dilatation can visually differentiate cardiac amyloidosis from hypertrophic cardiomyopathy
por: Higashi, Haruhiko, et al.
Publicado: (2021)

Impact of Earlier Diagnosis in Cardiac ATTR Amyloidosis Over the Course of 20 Years
por: Ioannou, Adam, et al.
Publicado: (2022)

Conventional heart failure therapy in cardiac ATTR amyloidosis
por: Ioannou, Adam, et al.
Publicado: (2023)

Transthyretin cardiac amyloidosis
por: Porcari, Aldostefano, et al.
Publicado: (2022)

Tracking Treatment Response in Cardiac Light-Chain Amyloidosis With Native T1 Mapping
por: Ioannou, Adam, et al.
Publicado: (2023)

(99m)Tc-DPD scintigraphy in immunoglobulin light chain (AL) cardiac amyloidosis
por: Quarta, Candida Cristina, et al.
Publicado: (2021)

Cardiac Amyloidosis: Updates in Imaging
por: Chacko, Liza, et al.
Publicado: (2019)

Characteristics and natural history of early-stage cardiac transthyretin amyloidosis
por: Law, Steven, et al.
Publicado: (2022)

Progression of echocardiographic parameters and prognosis in transthyretin cardiac amyloidosis
por: Chacko, Liza, et al.
Publicado: (2022)

Tc-99m labelled bone scintigraphy in suspected cardiac amyloidosis
por: Rauf, Muhammad Umaid, et al.
Publicado: (2023)

Safety of Catheter Ablation Therapy for Atrial Fibrillation in Cardiac Amyloidosis
por: Alhassan, Hassan A., et al.
Publicado: (2023)

Native T1 mapping in ATTR cardiac amyloidosis - comparison with AL cardiac amyloidosis - a 200 patient study
por: Fontana, Marianna, et al.
Publicado: (2014)

Early relapse is an adverse prognostic marker in systemic immunoglobulin light chain (AL) Amyloidosis
por: Ravichandran, Sriram, et al.
Publicado: (2022)

Cardiovascular magnetic resonance in light-chain amyloidosis to guide treatment
por: Martinez-Naharro, Ana, et al.
Publicado: (2022)

Impact of early response on outcomes in AL amyloidosis following treatment with frontline Bortezomib
por: Ravichandran, Sriram, et al.
Publicado: (2021)

Valve disease in cardiac amyloidosis: an echocardiographic score
por: Aimo, Alberto, et al.
Publicado: (2023)

Cardiac Amyloidosis Treatment
por: Stern, Lily K., et al.
Publicado: (2022)

Intracardiac melanoma metastases on (18)F-FDG PET-CT—a case report and review of literature with imaging features
por: Sweni, Shah, et al.
Publicado: (2019)

Stroke risk and atrial mechanical dysfunction in cardiac amyloidosis
por: Ballantyne, Brennan, et al.
Publicado: (2020)

How to treat atrial fibrillation in patients with cardiac amyloidosis
por: Nomoto, Yu, et al.
Publicado: (2023)

A multidisciplinary case report of multiple myeloma with renal and cardiac involvement: a look beyond amyloidosis
por: Innocenti, Samantha, et al.
Publicado: (2022)

Restrictive Atrial Dysfunction in Cardiac Amyloidosis: Differences between Immunoglobulin Light Chain and Transthyretin Cardiac Amyloidosis Patients
por: Versteylen, Mathijs O., et al.
Publicado: (2022)

Extracellular volume quantification by dynamic equilibrium cardiac computed tomography in cardiac amyloidosis
por: Treibel, Thomas A., et al.
Publicado: (2015)

Prevalence and Outcomes of Concomitant Aortic Stenosis and Cardiac Amyloidosis
por: Nitsche, Christian, et al.
Publicado: (2021)

Amyloidosis with Cardiac Involvement: Identification, Characterization, and Management
por: Jamal, Faizi, et al.
Publicado: (2021)

Primary Systemic Amyloidosis With Cardiac and Renal Involvement
por: Wong, Shin Ying, et al.
Publicado: (2022)

The impact and importance of achieving a complete haematological response prior to renal transplantation in AL amyloidosis
por: Cohen, Oliver C., et al.
Publicado: (2020)

Transcriptomics and Beyond in Dilated Cardiomyopathy
por: Cowan, Jason R., et al.
Publicado: (2023)

A Cardiac Amyloidosis Presentation: Atrial Mass Versus Thrombus
por: Nanda, Saheba, et al.
Publicado: (2020)

Electrical cardioversion of atrial arrhythmias with cardiac amyloidosis in the era of direct oral anticogulants
por: Touboul, Olivier, et al.
Publicado: (2022)

First case of cardiac amyloidosis presenting as right atrial mass
por: Acıbuca, Aynur, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_t9sq53iu9ujqb6cqs1vs91n05b